Navita L. Mallalieu
Michigan Medicine(US)
Publications by Year
Research Areas
Autoimmune and Inflammatory Disorders Research, Adolescent and Pediatric Healthcare, Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Low immunogenicity of tocilizumab in patients with rheumatoid arthritis(2016)101 cited
- → Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers(2020)52 cited
- → Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis(2021)35 cited
- → Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial(2019)24 cited
- → RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: Synthesis and biological evaluation(2005)21 cited
- → A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled basimglurant in humans(2016)17 cited
- → Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes(2013)16 cited
- → Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector(2019)15 cited
- → Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-Nucleoside Analogue Inhibitor(2014)10 cited
- → Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis(2006)10 cited